Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death ...

My doctor was of the opinion that over-medicalisation of patients was a common problem, and that a high PSA reading might ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

A new study suggests cholesterol-lowering statins, when combined with apalutamide and hormone therapy, can significantly ...

Teasing for gynaecomastia (enlarged male breast tissue) will unfortunately be familiar for many men and boys. But it's far ...

A common painkiller taken by millions could have cancer fighting properties, slashing the risk of womb, bowel, lung and ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

At 72, Judith McDaniel, a former oncology nurse, experienced cancer treatment after a routine mammogram led to her diagnosis ...

A vaccine designed to prevent and potentially treat triple-negative breast cancer is showing promise in human trials and ...

Alex Pattle spent the day with the UFC heavyweight champion, his father and coach Andy, and others close to the Wigan fighter ...

UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in ...